share_log

YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)

SEC ·  Feb 15 00:27
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.